Kewaunee Scientific Corporation KEQU Ratios & Valuation
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 28.5%-0.1pp | 28.6%+3.1pp | 25.5%+9.3pp | 16.2%+1.9pp | |
| Operating margin | 5.9%-1.5pp | 7.4%-1.6pp | 9%+6.5pp | 2.4%— | |
| Net margin | 3.4%-1.3pp | 4.7%-4.5pp | 9.2%+8.9pp | 0.3%+4.0pp | |
| Returns | |||||
| Return on equity | 13.8%-5.3pp | 19.1%-21.6pp | 40.7%+38.7pp | 2%+17.9pp | |
| Return on invested capital | 15.8%-9.3pp | 25.1%-22.8pp | 47.9%+40.7pp | 7.2%— | |
| Efficiency | |||||
| Asset turnover | 1.5×+0.1× | 1.5×-0.1× | 1.6×-0.2× | 1.8×+0.2× | |
| Liquidity | |||||
| Current ratio | 2.2×0.0× | 2.2×-0.2× | 2.4×+0.2× | 2.2×0.0× | |
| Leverage | |||||
| Debt-to-equity | 0.3×0.0× | 0.4×+0.2× | 0.2×-0.1× | 0.3×+0.1× | |
| Net debt / EBITDA | 0.7×+0.4× | 0.3×+1.0× | -0.7×-0.6× | -0.1×— | |
| Per Share | |||||
| Book value per share | $25.05+15.8% | $21.64+16.1% | $18.64+44.6% | $12.89+0.6% | |
| Valuation | |||||
| Market capitalization | $101.96M-34.8% | $97.81M-5.3% | $103.28M+125% | $45.99M+15.6% | |
| Price / earnings | 10.6×-3.1× | 8.6×+3.1× | 5.5×-56.8× | 62.3×— | |
| Price / sales | 0.4×-0.3× | 0.4×-0.1× | 0.5×+0.3× | 0.2×0.0× | |
| Price / book | 1.4×-1.1× | 1.5×-0.4× | 1.9×+0.7× | 1.2×+0.1× | |
| EV / EBITDA | 5.1×-2.1× | 4.6×+0.5× | 4.1×-1.4× | 5.5×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kewaunee Scientific Corporation's profit margins?
- Kewaunee Scientific Corporation (KEQU) runs a 28.5% gross margin and a 5.9% operating margin, with a 3.4% net margin.
- Where do Kewaunee Scientific Corporation's ratios come from?
- Every ratio is computed from Kewaunee Scientific Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
